Dividends & Buybacks ·
NexGel shareholders approve reverse stock split up to 1-for-20 and increase authorized shares to 150 million
NXGLNexgel, Inc.
NexGel, Inc. held its Special Meeting of Stockholders on September 23, 2026, where shareholders approved two key proposals. First, they authorized an amendment to the Certificate of Incorporation to increase the number of authorized common shares from 25,000,000 to up to 150,000,000 at the Board's discretion for one year. Second, shareholders approved a discretionary reverse stock split with a ratio ranging from 1-for-2 to 1-for-20, also at the Board's discretion within one year of approval. The company operates in the medical device industry, specifically focusing on regenerative medicine and tissue engineering solutions.